Priming with a “simplified regimen” of HIV-1 DNA vaccine is as good as a “standard regimen” when boosted with heterologous HIV-1 MVA vaccine

被引：0
|
作者：
P Munseri
A Kroidl
C Nilsson
C Moshiro
S Aboud
A Joachim
C Geldmacher
E Aris
D Buma
E Lyamuya
F Gotch
K Godoy-Ramirez
K Pallangyo
L Maboko
M Marovich
M Robb
M Hoelscher
M Janabi
P Mann
S Joseph
S Mfinanga
W Stoehr
F Mhalu
B Wahren
G Biberfeld
S McCormack
E Sandstrom
M Bakari
机构：
[1] Muhimbili University of Health and Allied Sciences,The Swedish Institute for Communicable Disease Control
[2] Department for Infectious Diseases and Tropical Medicine,Clinical Trials Unit
[3] SMI,undefined
[4] Division for Infectious Diseases and Tropical Medicine,undefined
[5] Imperial College,undefined
[6] Swedish Institute of Communicable Disease Control (SMI),undefined
[7] Mbeya Medical Research Programme,undefined
[8] Walter Reed Army Institute of Research (WRAIR),undefined
[9] The Henry M. Jackson foundation,undefined
[10] MRC,undefined
[11] National Institute for Medical Research,undefined
[12] Karolinska Institutet,undefined
[13] Swedish Institute for Communicable Disease Control (SMI),undefined
[14] MRC Clinical Trials Unit,undefined
[15] Venhalsan,undefined
[16] Karolinska Institutet,undefined
来源：
Retrovirology | / 9卷
关键词：
Placebo; Immune Response; Infectious Disease; Safety Concern; Cellular Immune Response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Priming with a "simplified regimen" of HIV-1 DNA vaccine is as good as a "standard regimen" when boosted with heterologous HIV-1 MVA vaccine
    Munseri, P.
    Kroidl, A.
    Nilsson, C.
    Moshiro, C.
    Aboud, S.
    Joachim, A.
    Geldmacher, C.
    Aris, E.
    Buma, D.
    Lyamuya, E.
    Gotch, F.
    Godoy-Ramirez, K.
    Pallangyo, K.
    Maboko, L.
    Marovich, M.
    Robb, M.
    Hoelscher, M.
    Janabi, M.
    Mann, P.
    Joseph, S.
    Mfinanga, S.
    Stoehr, W.
    Mhalu, F.
    Wahren, B.
    Biberfeld, G.
    McCormack, S.
    Sandstrom, E.
    Bakari, M.
    [J]. RETROVIROLOGY, 2012, 9
  • [2] Priming with a Simplified Intradermal HIV-1 DNA Vaccine Regimen followed by Boosting with Recombinant HIV-1 MVA Vaccine Is Safe and Immunogenic: A Phase IIa Randomized Clinical Trial
    Munseri, Patricia. J.
    Kroidl, Arne
    Nilsson, Charlotta
    Joachim, Agricola
    Geldmacher, Christof
    Mann, Philipp
    Moshiro, Candida
    Aboud, Said
    Lyamuya, Eligius
    Maboko, Leonard
    Missanga, Marco
    Kaluwa, Bahati
    Mfinanga, Sayoki
    Podola, Lilly
    Bauer, Asli
    Godoy-Ramirez, Karina
    Marovich, Mary
    Moss, Bernard
    Hoelscher, Michael
    Gotch, Frances
    Stoehr, Wolfgang
    Stout, Richard
    McCormack, Sheena
    Wahren, Britta
    Mhalu, Fred
    Robb, Merlin L.
    Biberfeld, Gunnel
    Sandstrom, Eric
    Bakari, Muhammad
    [J]. PLOS ONE, 2015, 10 (04):
  • [3] Safety and immunogenicity of a multigene multiclade HIV-1 DNA plasmid vaccine boosted with heterologous HIV-1 MVA among healthy volunteers in Dar es Salaam, Tanzania
    Aboud, S.
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2010, 15 (08) : S1 - S1
  • [4] Broad Immunogenicity of a Multigene, Multiclade HIV-1 DNA Vaccine Boosted with Heterologous HIV-1 Recombinant Modified Vaccinia Virus Ankara
    Sandstrom, Eric
    Nilsson, Charlotta
    Hejdeman, Bo
    Brave, Andreas
    Bratt, Goran
    Robb, Merlin
    Cox, Josephine
    VanCott, Thomas
    Marovich, Mary
    Stout, Richard
    Aboud, Said
    Bakari, Muhammad
    Pallangyo, Kisali
    Ljungberg, Karl
    Moss, Bernard
    Earl, Patricia
    Michael, Nelson
    Birx, Deborah
    Mhalu, Fred
    Wahren, Britta
    Biberfeld, Gunnel
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (10): : 1482 - 1490
  • [5] Breadth, phenotype and functionality of Gag-specific T cell responses induced by a heterologous DNA/MVA prime-boost HIV-1 vaccine regimen
    L Podola
    A Bauer
    A Haule
    L Sudi
    C Nilsson
    K Godoy-Ramirez
    P Mann
    M Missanga
    B Kaluwa
    L Maboko
    C Lueer
    M Mwakatima
    S Aboud
    M Bakari
    J Currier
    M Robb
    S McCormack
    S Joseph
    E Lyamuya
    M Hoelscher
    B Wahren
    E Sandström
    G Biberfeld
    C Geldmacher
    A Kroidl
    [J]. Retrovirology, 9
  • [6] Breadth, phenotype and functionality of Gag-specific T cell responses induced by a heterologous DNA/MVA prime-boost HIV-1 vaccine regimen
    Podola, L.
    Bauer, A.
    Haule, A.
    Sudi, L.
    Nilsson, C.
    Godoy-Ramirez, K.
    Mann, P.
    Missanga, M.
    Kaluwa, B.
    Maboko, L.
    Lueer, C.
    Mwakatima, M.
    Aboud, S.
    Bakari, M.
    Currier, J.
    Robb, M.
    McCormack, S.
    Joseph, S.
    Lyamuya, E.
    Hoelscher, M.
    Wahren, B.
    Sandstrom, E.
    Biberfeld, G.
    Geldmacher, C.
    Kroidl, A.
    [J]. RETROVIROLOGY, 2012, 9
  • [7] Safety profile of a multigene, multiclade HIV-1 DNA plasmid vaccine boosted with HIV-1 MVA among healthy volunteers in Dar es Salaam, Tanzania
    Francis, J.
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2010, 15 (08) : S1 - S2
  • [8] Safety and Immunogenicity of an HIV-1 DNA Plasmid Vaccine Boosted with HIV-1 MVA Among Police Officers (PO's) in Dar es Salaam, Tanzania
    Bakari, M.
    Mhalu, F.
    Aboud, S.
    Nilsson, C.
    Francis, J.
    Janabi, M.
    Lyamuya, E.
    Aris, E. A.
    Mbwana, J.
    Buma, D.
    Mwanyika, L.
    Hejdeman, B.
    Brave, A.
    Robb, M.
    Marovich, M.
    Michael, N.
    Earl, P.
    Wahren, B.
    Biberfeld, G.
    Pallangyo, K.
    Sandstrom, E.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 : 17 - 17
  • [9] Development of a candidate DNA/MVA HIV-1 subtype C vaccine for India
    Kumar, S
    Aggarwal, P
    Vajpayee, M
    Pandey, RM
    Seth, P
    [J]. VACCINE, 2006, 24 (14) : 2585 - 2593
  • [10] Immunogenicity of Lyophilized MVA Vaccine for HIV-1 in Mice Model
    ZHANG Yi-zhe
    [J]. Chemical Research in Chinese Universities, 2007, (03) : 329 - 332
12345